Albuquerque, NM, United States of America

Xingmao Jiang

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Xingmao Jiang in Cancer Treatment

Introduction

Xingmao Jiang is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer treatment through his innovative work on protocells. With a total of 7 patents, Jiang's inventions focus on targeted delivery systems that enhance the efficacy of cancer therapies.

Latest Patents

One of Jiang's latest patents is titled "Protocells and their use for targeted delivery of multicomponent cargos to cancer cells." This invention provides materials and methods for synthesizing protocells designed for the targeted delivery of cargo components specifically to cancer cells. In one embodiment, the lipid bilayer is fused to a porous particle core to create a protocell. The lipid bilayer can be modified with targeting ligands to ensure precise delivery of the loaded cargo to the target cancer cells. Additionally, shielding materials can be conjugated to the lipid bilayer's surface to minimize undesired non-specific binding.

Career Highlights

Throughout his career, Xingmao Jiang has worked with notable organizations such as Stc.unm and Sandia Corporation. His work in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer treatment technologies.

Collaborations

Some of Jiang's notable coworkers include C Jeffrey Brinker and Carlee Erin Ashley. Their collaborative efforts have further enhanced the research and development of protocell technologies.

Conclusion

Xingmao Jiang's innovative work in the field of cancer treatment through protocells showcases his dedication to improving targeted therapies. His contributions are paving the way for more effective cancer treatments, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…